While untreated mice quickly developed tumors, the NDV + Flt3L treatment protected from both primary and systemic tumor growth, with complete regression in the majority of mice (Fig. 4b–d), clearly demonstrating that the combined treatment induces efficient systemic anti-tumor immunity. Here, FLT3LG is linked to neoplasm.